Elevance Health, Inc. vs Eli Lilly & Co.
ELV vs LLY — side-by-side comparison from reported financials. ELV leads 4, LLY leads 8 of 12 comparable metrics.
Elevance Health, Inc.
ELV · Healthcare
$411.70+2.68%Strained
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | ELV | LLY |
|---|---|---|
| Price | $411.70 | $1 177.20 |
| Market cap | $89.3B | $1.05T |
| Revenue (TTM) | $201B | $79.7B |
| Revenue growth | +8.3% | +31.7% |
| Net margin | 2.5% | 33.5% |
| Free cash flow | $6.29B | $18.2B |
| Net cash (debt) | $4.43B | ($35.2B) |
| 1-year price return | +15.0% | +37.6% |
| P/E | 18.0 | 41.6 |
| P/E vs own history (cheap-side %) | 48% | 88% |
| Dividend yield | 1.68% | 0.52% |
| Return on equity | 11% | 93% |
| Altman Z-score | 1.33 | 7.10 |
| CV checks passed | 10 of 11 | 11 of 11 |
| Employees | 97,100 | 50,000 |
Full résumé-style profiles: ELV CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.